The Medtechy Daily: October 29

Posted on October 29, 2018 by Medtech[y] Staff

The Medtechy Daily provides the latest news and insight for the medical technology industry, including medical device, biotech and digital health.

Tweet of the Day


'We're shooting for thousands of clinics': A Silicon Valley startup has been quietly laying plans to take on heavyweight One Medical. We got the first look inside. When entrepreneur Eren Bali would tell his friends about his dream of building a physical healthcare clinic to complement the medical software app he'd created, they'd always brush it off as a joke. But starting last year, 34-year-old Bali began making his dream a reality. He began working with Caesar Djavaherian, an emergency medicine doctor who founded a network of urgent care clinics. (Business Insider)

Amazon Partners with Arcadia Group to Sell Home Health Products. According to an article from Christina Farr at CNBC, Amazon has teamed up with Arcadia Group to sell an exclusive new brand for Amazon called Choice. The initial focus will be consumer medical devices, including blood pressure cuffs and glucose monitors. (Medtechy)

Tesla to offer employees 'first-class' health clinics. More companies are moving towards offering employees on-site healthcare options as Elon Musk announced during Tesla's earnings call yesterday that the company recently opened a new and improved health clinic for employees. (Medtechy)

Should Stryker Worry About Zimmer's New Robotics Offering? Stryker's Mako Total Knee offering continues to gain traction and drive growth for the Kalamazoo, MI-based orthopedics company, but the company faces imminent competition in the space from Warsaw, IN-based Zimmer Biomet. (MDDI)

Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s commitment to studying breast implant safety. Choosing to obtain a breast implant, whether for augmentation or reconstruction, is a deeply personal choice, from the initial decision to undergo breast implant surgery to the size, material and surface texture. (FDA Press Release)

Novartis, Pfizer join forces on potentially lucrative fatty liver disease. Novartis AG and Pfizer Inc are teaming up to develop treatments for a liver disease many drug companies believe will become a hugely lucrative market, as it is tied to the obesity and diabetes epidemics. (Reuters)

Synagogue attack victim Dr. Jerry Rabinowitz rushed at gunfire to help the wounded. The gunman didn’t ambush Dr. Jerry Rabinowitz during prayers. As the shooter stalked his victims in the Tree of Life synagogue in Pittsburgh, Rabinowitz rushed to help the wounded, according to his nephew Avishai Ostrin. (NBC News)